Rank | Gene Set | Z-score |
---|---|---|
1 | NIK/NF-kappaB signaling (GO:0038061) | 6.70838984 |
2 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.99378838 |
3 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.81037337 |
4 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.81037337 |
5 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.79454148 |
6 | regulation of vitamin D biosynthetic process (GO:0060556) | 5.62961424 |
7 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 5.22370702 |
8 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 5.02152021 |
9 | negative thymic T cell selection (GO:0045060) | 4.97455520 |
10 | negative T cell selection (GO:0043383) | 4.93097434 |
11 | negative regulation of interleukin-12 production (GO:0032695) | 4.76913217 |
12 | response to muramyl dipeptide (GO:0032495) | 4.58684575 |
13 | regulation of vitamin metabolic process (GO:0030656) | 4.44136614 |
14 | negative regulation of cell killing (GO:0031342) | 4.34145221 |
15 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.34145221 |
16 | T cell migration (GO:0072678) | 4.31085228 |
17 | regulation of cytokine secretion involved in immune response (GO:0002739) | 4.27997177 |
18 | myeloid dendritic cell differentiation (GO:0043011) | 4.25137389 |
19 | regulation of gamma-delta T cell activation (GO:0046643) | 4.24966965 |
20 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.24380216 |
21 | tolerance induction (GO:0002507) | 4.18553337 |
22 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 4.12748531 |
23 | positive regulation of heat generation (GO:0031652) | 4.08303221 |
24 | regulation of fever generation (GO:0031620) | 4.04434835 |
25 | positive regulation of humoral immune response (GO:0002922) | 4.04150061 |
26 | myeloid dendritic cell activation (GO:0001773) | 4.02583334 |
27 | positive thymic T cell selection (GO:0045059) | 4.01971389 |
28 | positive regulation of interleukin-2 production (GO:0032743) | 4.01803213 |
29 | response to interleukin-15 (GO:0070672) | 4.01085839 |
30 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.98088544 |
31 | response to protozoan (GO:0001562) | 3.94467865 |
32 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.94216439 |
33 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.94019958 |
34 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.93641178 |
35 | cellular response to interleukin-15 (GO:0071350) | 3.93274432 |
36 | regulation of T cell tolerance induction (GO:0002664) | 3.90381120 |
37 | regulation of podosome assembly (GO:0071801) | 3.90284606 |
38 | T-helper 1 type immune response (GO:0042088) | 3.89538287 |
39 | thymic T cell selection (GO:0045061) | 3.87663671 |
40 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.85422713 |
41 | positive regulation of antigen processing and presentation (GO:0002579) | 3.85265175 |
42 | positive regulation of interleukin-12 production (GO:0032735) | 3.83344120 |
43 | response to type I interferon (GO:0034340) | 3.81887915 |
44 | type I interferon signaling pathway (GO:0060337) | 3.81539804 |
45 | cellular response to type I interferon (GO:0071357) | 3.81539804 |
46 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.81137195 |
47 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.78870221 |
48 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.78609816 |
49 | T cell selection (GO:0045058) | 3.76297444 |
50 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.74449713 |
51 | T-helper cell differentiation (GO:0042093) | 3.70349442 |
52 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 3.70349442 |
53 | macrophage activation involved in immune response (GO:0002281) | 3.69001666 |
54 | interferon-gamma production (GO:0032609) | 3.68937919 |
55 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.67629365 |
56 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.66959133 |
57 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.65290361 |
58 | regulation of chemokine biosynthetic process (GO:0045073) | 3.61818579 |
59 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.60241365 |
60 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.59767393 |
61 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.59000636 |
62 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.56774013 |
63 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.56008212 |
64 | positive regulation of type 2 immune response (GO:0002830) | 3.55980678 |
65 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.55241331 |
66 | regulation of T-helper cell differentiation (GO:0045622) | 3.54690043 |
67 | leukocyte aggregation (GO:0070486) | 3.50352021 |
68 | regulation of chronic inflammatory response (GO:0002676) | 3.48157973 |
69 | regulation of RIG-I signaling pathway (GO:0039535) | 3.47222476 |
70 | positive T cell selection (GO:0043368) | 3.46815530 |
71 | neutrophil activation involved in immune response (GO:0002283) | 3.45395946 |
72 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 3.43246511 |
73 | alpha-beta T cell activation involved in immune response (GO:0002287) | 3.43246511 |
74 | T cell differentiation involved in immune response (GO:0002292) | 3.43246511 |
75 | mature B cell differentiation (GO:0002335) | 3.39447982 |
76 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 3.38778593 |
77 | positive regulation of isotype switching (GO:0045830) | 3.38515110 |
78 | regulation of antigen processing and presentation (GO:0002577) | 3.38298400 |
79 | regulation of interleukin-12 production (GO:0032655) | 3.38154310 |
80 | growth hormone receptor signaling pathway (GO:0060396) | 3.36536283 |
81 | positive regulation of T cell cytokine production (GO:0002726) | 3.36399362 |
82 | positive regulation of interferon-alpha production (GO:0032727) | 3.35174476 |
83 | natural killer cell mediated immunity (GO:0002228) | 3.34448030 |
84 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.34448030 |
85 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.31571873 |
86 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 3.30489044 |
87 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.30087921 |
88 | positive regulation of T-helper cell differentiation (GO:0045624) | 3.29315463 |
89 | T cell activation involved in immune response (GO:0002286) | 3.26726705 |
90 | regulation of tolerance induction (GO:0002643) | 3.26590274 |
91 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.26490575 |
92 | regulation of immunoglobulin secretion (GO:0051023) | 3.25583719 |
93 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 3.25170970 |
94 | neutrophil activation (GO:0042119) | 3.24315987 |
95 | regulation of interferon-alpha production (GO:0032647) | 3.24302216 |
96 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.23982079 |
97 | lymphocyte migration (GO:0072676) | 3.21567597 |
98 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 3.19556590 |
99 | granulocyte activation (GO:0036230) | 3.19474997 |
100 | germinal center formation (GO:0002467) | 3.17165739 |
101 | dendritic cell differentiation (GO:0097028) | 3.14672255 |
102 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.14635283 |
103 | regulation of response to interferon-gamma (GO:0060330) | 3.14355106 |
104 | activation of MAPKKK activity (GO:0000185) | 3.14051907 |
105 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 3.13836209 |
106 | cellular response to interferon-gamma (GO:0071346) | 3.13705039 |
107 | response to peptidoglycan (GO:0032494) | 3.12780160 |
108 | negative regulation of T cell mediated immunity (GO:0002710) | 3.11960566 |
109 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 3.11723189 |
110 | positive regulation of B cell mediated immunity (GO:0002714) | 3.10935445 |
111 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 3.10935445 |
112 | immunoglobulin mediated immune response (GO:0016064) | 3.10280880 |
113 | regulation of interleukin-2 production (GO:0032663) | 3.09995891 |
114 | alpha-beta T cell activation (GO:0046631) | 3.07769975 |
115 | negative regulation of viral genome replication (GO:0045071) | 3.07458294 |
116 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.07162938 |
117 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 3.04877959 |
118 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.04567337 |
119 | regulation of heat generation (GO:0031650) | 3.04468010 |
120 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.03778225 |
121 | T cell costimulation (GO:0031295) | 3.03121149 |
122 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.02822631 |
123 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 3.01749174 |
124 | positive regulation of defense response to virus by host (GO:0002230) | 3.00476694 |
125 | natural killer cell activation (GO:0030101) | 2.99936577 |
126 | defense response to protozoan (GO:0042832) | 2.99843479 |
127 | positive regulation by symbiont of host defense response (GO:0052509) | 2.98980932 |
128 | modulation by symbiont of host defense response (GO:0052031) | 2.98980932 |
129 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.98980932 |
130 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.98980932 |
131 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.98980932 |
132 | modulation by symbiont of host immune response (GO:0052553) | 2.98980932 |
133 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.98852694 |
134 | positive regulation of interleukin-17 production (GO:0032740) | 2.98749306 |
135 | positive regulation of T-helper 1 type immune response (GO:0002827) | 2.98459834 |
136 | positive regulation of cytokine biosynthetic process (GO:0042108) | 2.98379158 |
137 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.97662996 |
138 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.97299819 |
139 | positive regulation of interleukin-10 production (GO:0032733) | 2.92419754 |
140 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 2.92085732 |
141 | regulation of growth of symbiont in host (GO:0044126) | 2.92085732 |
142 | negative regulation of growth of symbiont in host (GO:0044130) | 2.92085732 |
143 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.92085732 |
144 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.91263593 |
145 | cellular response to lipopolysaccharide (GO:0071222) | 2.91213061 |
Rank | Gene Set | Z-score |
---|---|---|
1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 6.94491832 |
2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.44554581 |
3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.25321827 |
4 | * STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 5.18971980 |
5 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.82873660 |
6 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.75012636 |
7 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.96152633 |
8 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.53002289 |
9 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.52771496 |
10 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.39914858 |
11 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.24106948 |
12 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.21939854 |
13 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.13548546 |
14 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.09443447 |
15 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.06918510 |
16 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.94968714 |
17 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.88087749 |
18 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.84979218 |
19 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.80651920 |
20 | MYB_26560356_Chip-Seq_TH2_Human | 2.71274780 |
21 | * MAF_26560356_Chip-Seq_TH1_Human | 2.45894586 |
22 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.42682089 |
23 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.34868313 |
24 | MYB_26560356_Chip-Seq_TH1_Human | 2.26084973 |
25 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.19768978 |
26 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.11170555 |
27 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.08188142 |
28 | MYC_22102868_ChIP-Seq_BL_Human | 1.90067081 |
29 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.87933148 |
30 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.82961997 |
31 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.77659746 |
32 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.76539655 |
33 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.75998832 |
34 | UTX_26944678_Chip-Seq_JUKART_Human | 1.73786049 |
35 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.72165796 |
36 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.65002803 |
37 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.63787121 |
38 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.63183595 |
39 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.62401948 |
40 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.60843771 |
41 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.60144734 |
42 | MAF_26560356_Chip-Seq_TH2_Human | 1.58286018 |
43 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.56490708 |
44 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.54385043 |
45 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.53541840 |
46 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.49289238 |
47 | SPI1_23127762_ChIP-Seq_K562_Human | 1.46944762 |
48 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.46524296 |
49 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.37399317 |
50 | GATA3_26560356_Chip-Seq_TH2_Human | 1.36574295 |
51 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.32319876 |
52 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.30343894 |
53 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.30154274 |
54 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.28207583 |
55 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.27410236 |
56 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.21266925 |
57 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.20816241 |
58 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.20109887 |
59 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18280252 |
60 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.17780276 |
61 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.17696024 |
62 | GATA1_22025678_ChIP-Seq_K562_Human | 1.10501757 |
63 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.08625544 |
64 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.06415032 |
65 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.03799844 |
66 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.01968093 |
67 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.01943248 |
68 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98077064 |
69 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.97218008 |
70 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.94338790 |
71 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.91039458 |
72 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.89766268 |
73 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.89183572 |
74 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.89114642 |
75 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.88543224 |
76 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.87644348 |
77 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.87169195 |
78 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.83646520 |
79 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.83076196 |
80 | * SMRT_27268052_Chip-Seq_Bcells_Human | 0.81337314 |
81 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.81115918 |
82 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.80391868 |
83 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.79870907 |
84 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.78970140 |
85 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.76974826 |
86 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.76221823 |
87 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.75961553 |
88 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.75587602 |
89 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.75387566 |
90 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.74433898 |
91 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.73773811 |
92 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.72590165 |
93 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.72466818 |
94 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.72466818 |
95 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.72232071 |
96 | * BCOR_27268052_Chip-Seq_Bcells_Human | 0.70930657 |
97 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.70648341 |
98 | * BCL6_27268052_Chip-Seq_Bcells_Human | 0.69882399 |
99 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.69478190 |
100 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.68838119 |
101 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.68654514 |
102 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.68653743 |
103 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.68204008 |
104 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.67432727 |
105 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.66078872 |
106 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.65798014 |
107 | GATA2_19941826_ChIP-Seq_K562_Human | 0.65326944 |
108 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.65108007 |
109 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.61895576 |
110 | * NCOR1_26117541_ChIP-Seq_K562_Human | 0.59017443 |
111 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.58771332 |
112 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.56933415 |
113 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.56643916 |
114 | GATA1_19941826_ChIP-Seq_K562_Human | 0.55006027 |
115 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.54860730 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001835_abnormal_antigen_presentation | 4.63312248 |
2 | MP0000685_abnormal_immune_system | 3.96974319 |
3 | MP0005671_abnormal_response_to | 3.76411001 |
4 | MP0004510_myositis | 3.54344664 |
5 | MP0005387_immune_system_phenotype | 3.52862500 |
6 | MP0001790_abnormal_immune_system | 3.52862500 |
7 | MP0009785_altered_susceptibility_to | 3.43809026 |
8 | MP0001800_abnormal_humoral_immune | 3.26791582 |
9 | MP0005000_abnormal_immune_tolerance | 3.25461816 |
10 | MP0002138_abnormal_hepatobiliary_system | 3.25343163 |
11 | MP0003436_decreased_susceptibility_to | 3.14499219 |
12 | MP0002148_abnormal_hypersensitivity_rea | 3.00503795 |
13 | MP0002723_abnormal_immune_serum | 2.89422320 |
14 | MP0002452_abnormal_antigen_presenting | 2.88081992 |
15 | MP0003763_abnormal_thymus_physiology | 2.87869859 |
16 | MP0003303_peritoneal_inflammation | 2.74980887 |
17 | MP0005025_abnormal_response_to | 2.70943269 |
18 | MP0002166_altered_tumor_susceptibility | 2.66977834 |
19 | * MP0001819_abnormal_immune_cell | 2.63814584 |
20 | * MP0002420_abnormal_adaptive_immunity | 2.62620754 |
21 | MP0002419_abnormal_innate_immunity | 2.51520473 |
22 | MP0002006_tumorigenesis | 2.42685623 |
23 | MP0006082_CNS_inflammation | 2.39765784 |
24 | MP0003724_increased_susceptibility_to | 2.36229272 |
25 | MP0004947_skin_inflammation | 2.27129059 |
26 | MP0002405_respiratory_system_inflammati | 2.25839873 |
27 | MP0002254_reproductive_system_inflammat | 2.21328712 |
28 | MP0005451_abnormal_body_composition | 2.16090232 |
29 | * MP0002398_abnormal_bone_marrow | 2.14640968 |
30 | * MP0000716_abnormal_immune_system | 2.09281349 |
31 | MP0001873_stomach_inflammation | 2.07729848 |
32 | MP0010155_abnormal_intestine_physiology | 2.03200099 |
33 | MP0005310_abnormal_salivary_gland | 2.02243901 |
34 | MP0001853_heart_inflammation | 1.97241749 |
35 | MP0009333_abnormal_splenocyte_physiolog | 1.94585398 |
36 | MP0003300_gastrointestinal_ulcer | 1.86246331 |
37 | MP0001845_abnormal_inflammatory_respons | 1.77864373 |
38 | MP0002139_abnormal_hepatobiliary_system | 1.77576148 |
39 | MP0001348_abnormal_lacrimal_gland | 1.69894034 |
40 | MP0000689_abnormal_spleen_morphology | 1.65652239 |
41 | * MP0002429_abnormal_blood_cell | 1.64480012 |
42 | MP0008004_abnormal_stomach_pH | 1.63247266 |
43 | * MP0002722_abnormal_immune_system | 1.60849660 |
44 | MP0009840_abnormal_foam_cell | 1.57562374 |
45 | MP0001533_abnormal_skeleton_physiology | 1.51598322 |
46 | MP0002277_abnormal_respiratory_mucosa | 1.49823234 |
47 | MP0002332_abnormal_exercise_endurance | 1.49037916 |
48 | MP0003448_altered_tumor_morphology | 1.48864015 |
49 | MP0005464_abnormal_platelet_physiology | 1.48278569 |
50 | MP0000703_abnormal_thymus_morphology | 1.47744609 |
51 | MP0005167_abnormal_blood-brain_barrier | 1.45165476 |
52 | MP0002933_joint_inflammation | 1.42807334 |
53 | MP0002009_preneoplasia | 1.39337036 |
54 | MP0008469_abnormal_protein_level | 1.35139934 |
55 | MP0003866_abnormal_defecation | 1.32270787 |
56 | MP0009764_decreased_sensitivity_to | 1.28431796 |
57 | MP0002163_abnormal_gland_morphology | 1.26343022 |
58 | MP0000569_abnormal_digit_pigmentation | 1.22755638 |
59 | MP0000858_altered_metastatic_potential | 1.18040723 |
60 | MP0002998_abnormal_bone_remodeling | 1.15708453 |
61 | MP0005397_hematopoietic_system_phenotyp | 1.12510999 |
62 | MP0001545_abnormal_hematopoietic_system | 1.12510999 |
63 | MP0002396_abnormal_hematopoietic_system | 1.11376885 |
64 | MP0005076_abnormal_cell_differentiation | 1.09600140 |
65 | MP0003453_abnormal_keratinocyte_physiol | 1.07695421 |
66 | MP0010352_gastrointestinal_tract_polyps | 1.04944403 |
67 | MP0009278_abnormal_bone_marrow | 1.04406464 |
68 | MP0003091_abnormal_cell_migration | 1.03981629 |
69 | MP0003656_abnormal_erythrocyte_physiolo | 1.00288784 |
70 | MP0003690_abnormal_glial_cell | 0.99838489 |
71 | MP0000604_amyloidosis | 0.97702074 |
72 | MP0005058_abnormal_lysosome_morphology | 0.95245115 |
73 | MP0004808_abnormal_hematopoietic_stem | 0.94186363 |
74 | MP0002877_abnormal_melanocyte_morpholog | 0.93715326 |
75 | MP0001851_eye_inflammation | 0.90923456 |
76 | MP0006054_spinal_hemorrhage | 0.89250387 |
77 | MP0003172_abnormal_lysosome_physiology | 0.86214378 |
78 | MP0003195_calcinosis | 0.85653151 |
79 | MP0005174_abnormal_tail_pigmentation | 0.81810645 |
80 | MP0003806_abnormal_nucleotide_metabolis | 0.79256874 |
81 | MP0003045_fibrosis | 0.77817737 |
82 | MP0005164_abnormal_response_to | 0.75169057 |
83 | MP0001501_abnormal_sleep_pattern | 0.75117879 |
84 | MP0003191_abnormal_cellular_cholesterol | 0.74123298 |
85 | MP0008874_decreased_physiological_sensi | 0.73583870 |
86 | MP0008057_abnormal_DNA_replication | 0.72344172 |
87 | MP0009763_increased_sensitivity_to | 0.72084434 |
88 | MP0000490_abnormal_crypts_of | 0.69858977 |
89 | MP0001881_abnormal_mammary_gland | 0.69679520 |
90 | MP0003183_abnormal_peptide_metabolism | 0.67986247 |
91 | MP0000465_gastrointestinal_hemorrhage | 0.67781933 |
92 | MP0000249_abnormal_blood_vessel | 0.67564565 |
93 | MP0000343_altered_response_to | 0.66614770 |
94 | MP0003646_muscle_fatigue | 0.66448586 |
95 | MP0005165_increased_susceptibility_to | 0.65400587 |
96 | MP0003828_pulmonary_edema | 0.65147797 |
97 | MP0002136_abnormal_kidney_physiology | 0.64772327 |
98 | MP0005535_abnormal_body_temperature | 0.64150115 |
99 | MP0001346_abnormal_lacrimal_gland | 0.63922456 |
100 | MP0005390_skeleton_phenotype | 0.62085630 |
101 | MP0010307_abnormal_tumor_latency | 0.61935287 |
102 | MP0009765_abnormal_xenobiotic_induced | 0.61679908 |
103 | MP0000920_abnormal_myelination | 0.60788755 |
104 | MP0003075_altered_response_to | 0.59210797 |
105 | MP0002019_abnormal_tumor_incidence | 0.58480379 |
106 | MP0008260_abnormal_autophagy | 0.58422730 |
107 | MP0001542_abnormal_bone_strength | 0.58260336 |
108 | MP0001243_abnormal_dermal_layer | 0.57372019 |
109 | MP0005647_abnormal_sex_gland | 0.57297855 |
110 | MP0005166_decreased_susceptibility_to | 0.54505963 |
111 | MP0000627_abnormal_mammary_gland | 0.54240139 |
112 | MP0001191_abnormal_skin_condition | 0.53644059 |
113 | MP0000609_abnormal_liver_physiology | 0.53375030 |
114 | MP0000371_diluted_coat_color | 0.52940839 |
115 | MP0001216_abnormal_epidermal_layer | 0.52191126 |
116 | MP0001663_abnormal_digestive_system | 0.51196917 |
117 | MP0003795_abnormal_bone_structure | 0.50230976 |
118 | MP0005379_endocrine/exocrine_gland_phen | 0.49349798 |
119 | MP0004381_abnormal_hair_follicle | 0.49069987 |
120 | MP0000015_abnormal_ear_pigmentation | 0.47194288 |
121 | MP0004782_abnormal_surfactant_physiolog | 0.45201094 |
122 | MP0002693_abnormal_pancreas_physiology | 0.44521522 |
123 | MP0005023_abnormal_wound_healing | 0.41972838 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Eczematoid dermatitis (HP:0000976) | 5.61766299 |
2 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.60234148 |
3 | Stomatitis (HP:0010280) | 5.57417778 |
4 | Retrobulbar optic neuritis (HP:0100654) | 5.35671338 |
5 | Optic neuritis (HP:0100653) | 5.35671338 |
6 | Recurrent abscess formation (HP:0002722) | 5.13747627 |
7 | Myositis (HP:0100614) | 5.06503278 |
8 | Recurrent fungal infections (HP:0002841) | 4.90984111 |
9 | Orchitis (HP:0100796) | 4.87334011 |
10 | Chronic otitis media (HP:0000389) | 4.87281643 |
11 | Abnormality of glycolipid metabolism (HP:0010969) | 4.77901986 |
12 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.77901986 |
13 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.77901986 |
14 | Recurrent bacterial skin infections (HP:0005406) | 4.74902811 |
15 | Recurrent viral infections (HP:0004429) | 4.59631419 |
16 | Mediastinal lymphadenopathy (HP:0100721) | 4.54342561 |
17 | Nasal polyposis (HP:0100582) | 4.40214174 |
18 | Increased IgM level (HP:0003496) | 4.24634767 |
19 | Vasculitis (HP:0002633) | 4.20674558 |
20 | Abnormality of T cell number (HP:0011839) | 4.13692483 |
21 | Recurrent bronchitis (HP:0002837) | 4.06454223 |
22 | Pulmonary infiltrates (HP:0002113) | 3.99475272 |
23 | T lymphocytopenia (HP:0005403) | 3.94084077 |
24 | Recurrent cutaneous fungal infections (HP:0011370) | 3.89141993 |
25 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.89141993 |
26 | Gastrointestinal infarctions (HP:0005244) | 3.83427167 |
27 | Abnormality of the nasal mucosa (HP:0000433) | 3.78524949 |
28 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.72928528 |
29 | Recurrent skin infections (HP:0001581) | 3.64247059 |
30 | Loss of speech (HP:0002371) | 3.62133223 |
31 | Arterial thrombosis (HP:0004420) | 3.49530889 |
32 | Abnormality of macrophages (HP:0004311) | 3.46777859 |
33 | Autoimmune thrombocytopenia (HP:0001973) | 3.42348154 |
34 | Vacuolated lymphocytes (HP:0001922) | 3.38830105 |
35 | Abnormality of T cells (HP:0002843) | 3.35696739 |
36 | Leukocytosis (HP:0001974) | 3.35232747 |
37 | Panhypogammaglobulinemia (HP:0003139) | 3.34426542 |
38 | Agammaglobulinemia (HP:0004432) | 3.34152534 |
39 | Systemic lupus erythematosus (HP:0002725) | 3.34059708 |
40 | Keratoconjunctivitis sicca (HP:0001097) | 3.32011955 |
41 | Dysostosis multiplex (HP:0000943) | 3.28116032 |
42 | Meningitis (HP:0001287) | 3.27603631 |
43 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.21880355 |
44 | Colitis (HP:0002583) | 3.19388936 |
45 | Increased IgE level (HP:0003212) | 3.18331824 |
46 | Keratoconjunctivitis (HP:0001096) | 3.15450571 |
47 | Hemoptysis (HP:0002105) | 3.14523782 |
48 | Eosinophilia (HP:0001880) | 3.13378792 |
49 | Obstructive lung disease (HP:0006536) | 3.13077532 |
50 | Chronic obstructive pulmonary disease (HP:0006510) | 3.13077532 |
51 | Disinhibition (HP:0000734) | 3.12502654 |
52 | Inflammation of the large intestine (HP:0002037) | 3.11859465 |
53 | Hypergammaglobulinemia (HP:0010702) | 3.07562097 |
54 | Interstitial pulmonary disease (HP:0006530) | 3.05883012 |
55 | Increased cerebral lipofuscin (HP:0011813) | 3.03074016 |
56 | Gingivitis (HP:0000230) | 3.01611431 |
57 | Chronic diarrhea (HP:0002028) | 3.00886717 |
58 | IgG deficiency (HP:0004315) | 3.00200946 |
59 | Abnormality of eosinophils (HP:0001879) | 2.95786806 |
60 | Chronic sinusitis (HP:0011109) | 2.92335954 |
61 | Gastrointestinal inflammation (HP:0004386) | 2.90782347 |
62 | Pustule (HP:0200039) | 2.90604919 |
63 | IgA deficiency (HP:0002720) | 2.84935805 |
64 | Severe combined immunodeficiency (HP:0004430) | 2.83444987 |
65 | Abnormality of T cell physiology (HP:0011840) | 2.80932724 |
66 | Joint swelling (HP:0001386) | 2.79139024 |
67 | IgM deficiency (HP:0002850) | 2.78970599 |
68 | Fatigue (HP:0012378) | 2.78301112 |
69 | Gastrointestinal stroma tumor (HP:0100723) | 2.77867097 |
70 | Encephalitis (HP:0002383) | 2.77796101 |
71 | Abnormality of the fingertips (HP:0001211) | 2.74935519 |
72 | Lymphopenia (HP:0001888) | 2.71846365 |
73 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.71163754 |
74 | Emphysema (HP:0002097) | 2.71046840 |
75 | Granulocytopenia (HP:0001913) | 2.70588894 |
76 | Combined immunodeficiency (HP:0005387) | 2.64780272 |
77 | Hematochezia (HP:0002573) | 2.63259255 |
78 | Periodontitis (HP:0000704) | 2.62028223 |
79 | Autoimmune hemolytic anemia (HP:0001890) | 2.60890524 |
80 | Thyroiditis (HP:0100646) | 2.54226902 |
81 | Abnormality of the pleura (HP:0002103) | 2.52780487 |
82 | Cellulitis (HP:0100658) | 2.52609424 |
83 | Thrombocytosis (HP:0001894) | 2.51598556 |
84 | Recurrent sinusitis (HP:0011108) | 2.51582554 |
85 | Myocardial infarction (HP:0001658) | 2.45473657 |
86 | Polyneuropathy (HP:0001271) | 2.43788051 |
87 | Mutism (HP:0002300) | 2.43413195 |
88 | Parakeratosis (HP:0001036) | 2.42796160 |
89 | Chest pain (HP:0100749) | 2.42507830 |
90 | Nuclear cataract (HP:0100018) | 2.41765684 |
91 | Increased serum ferritin (HP:0003281) | 2.41235229 |
92 | Gingival bleeding (HP:0000225) | 2.39194035 |
93 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.34568694 |
94 | Spontaneous hematomas (HP:0007420) | 2.32998204 |
95 | Bronchitis (HP:0012387) | 2.32406297 |
96 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.31609773 |
97 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.31609773 |
98 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.31609773 |
99 | Persistence of primary teeth (HP:0006335) | 2.30201639 |
100 | Osteomyelitis (HP:0002754) | 2.25058452 |
101 | Abnormality of B cell number (HP:0010975) | 2.23322577 |
102 | B lymphocytopenia (HP:0010976) | 2.23322577 |
103 | Porencephaly (HP:0002132) | 2.22395193 |
104 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.20904732 |
105 | Mucopolysacchariduria (HP:0008155) | 2.20904732 |
106 | Basal ganglia calcification (HP:0002135) | 2.17015468 |
107 | Arthralgia (HP:0002829) | 2.16358381 |
108 | Glomerulopathy (HP:0100820) | 2.14977372 |
109 | Anorexia (HP:0002039) | 2.14046642 |
110 | Apathy (HP:0000741) | 2.11819429 |
111 | Glomerulonephritis (HP:0000099) | 2.10609417 |
112 | Neurofibrillary tangles (HP:0002185) | 2.10395575 |
113 | Gangrene (HP:0100758) | 2.10076697 |
114 | Pulmonary embolism (HP:0002204) | 2.08575526 |
115 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.08133318 |
116 | Tetraparesis (HP:0002273) | 2.05594333 |
117 | Premature loss of primary teeth (HP:0006323) | 2.05526941 |
118 | Prostate neoplasm (HP:0100787) | 2.05431949 |
119 | Recurrent pneumonia (HP:0006532) | 2.04453377 |
120 | Neuronal loss in central nervous system (HP:0002529) | 2.04245856 |
121 | Restrictive lung disease (HP:0002091) | 2.04010026 |
122 | Hypertensive crisis (HP:0100735) | 2.03786855 |
123 | Amaurosis fugax (HP:0100576) | 2.03556076 |
124 | Abnormality of the pericardium (HP:0001697) | 2.01656530 |
125 | Skin ulcer (HP:0200042) | 2.01458713 |
126 | Diminished motivation (HP:0000745) | 2.00900493 |
127 | Urticaria (HP:0001025) | 2.00767602 |
128 | Abnormality of the prostate (HP:0008775) | 1.98792841 |
129 | Recurrent lower respiratory tract infections (HP:0002783) | 1.95023442 |
130 | Peritonitis (HP:0002586) | 1.93177279 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP3K14 | 5.32118707 |
2 | MAP4K1 | 3.97380642 |
3 | TYK2 | 3.71974824 |
4 | JAK3 | 3.63236787 |
5 | TXK | 3.59890207 |
6 | PRPF4B | 3.42475056 |
7 | TBK1 | 3.41355771 |
8 | MAP3K13 | 3.33126775 |
9 | IKBKE | 3.30234035 |
10 | IKBKB | 3.07708364 |
11 | JAK1 | 2.79284998 |
12 | TAOK2 | 2.66277825 |
13 | GRK7 | 2.52171964 |
14 | IRAK3 | 2.46426908 |
15 | IRAK4 | 2.41664064 |
16 | CHUK | 2.37089464 |
17 | BLK | 2.33761310 |
18 | FGFR4 | 2.28090484 |
19 | DDR2 | 2.23794735 |
20 | MATK | 2.21823802 |
21 | EPHB1 | 2.08963603 |
22 | RIPK4 | 1.94079491 |
23 | ITK | 1.87916969 |
24 | ZAP70 | 1.86294736 |
25 | EPHA3 | 1.78298635 |
26 | RIPK1 | 1.74718195 |
27 | TAOK1 | 1.67238390 |
28 | FGFR3 | 1.66118424 |
29 | KIT | 1.63427262 |
30 | MAP3K11 | 1.54469775 |
31 | CSK | 1.53276407 |
32 | STK10 | 1.50708009 |
33 | CDC42BPA | 1.50319758 |
34 | LCK | 1.45284822 |
35 | SYK | 1.42546715 |
36 | NLK | 1.38247754 |
37 | MOS | 1.35962248 |
38 | MST4 | 1.34455719 |
39 | TAOK3 | 1.28171759 |
40 | HCK | 1.26262960 |
41 | BTK | 1.23898877 |
42 | TEC | 1.23888600 |
43 | IRAK1 | 1.18735553 |
44 | PIM1 | 1.12758020 |
45 | JAK2 | 1.12682984 |
46 | GRK6 | 1.11828787 |
47 | RPS6KA4 | 1.11738103 |
48 | TYRO3 | 1.11368160 |
49 | CSF1R | 1.11293037 |
50 | SIK2 | 1.03313560 |
51 | SIK3 | 0.99995487 |
52 | PRKCQ | 0.96499023 |
53 | MARK3 | 0.93149131 |
54 | MAP3K10 | 0.82674812 |
55 | FES | 0.82187104 |
56 | PIM2 | 0.80670199 |
57 | LYN | 0.79820507 |
58 | ADRBK2 | 0.78926890 |
59 | FGR | 0.77697073 |
60 | NEK9 | 0.75726124 |
61 | LRRK2 | 0.71350396 |
62 | BMPR2 | 0.65239143 |
63 | CDK12 | 0.65105642 |
64 | PTK6 | 0.64865126 |
65 | SMG1 | 0.55302070 |
66 | EIF2AK2 | 0.52454690 |
67 | TRIB3 | 0.52306855 |
68 | PRKAA2 | 0.51275430 |
69 | RPS6KA5 | 0.50691302 |
70 | MAPK4 | 0.49946612 |
71 | MAP2K3 | 0.49070875 |
72 | MAPKAPK2 | 0.47865884 |
73 | MAPK7 | 0.46420161 |
74 | MAPK11 | 0.45262711 |
75 | ALK | 0.43112685 |
76 | STK4 | 0.42679801 |
77 | PDGFRA | 0.42535098 |
78 | FLT3 | 0.42252801 |
79 | EGFR | 0.41879104 |
80 | TNK2 | 0.41870303 |
81 | ABL1 | 0.41788504 |
82 | TGFBR2 | 0.41377545 |
83 | BMX | 0.40489340 |
84 | HIPK2 | 0.39708330 |
85 | CLK1 | 0.39622597 |
86 | PRKCD | 0.39264650 |
87 | ICK | 0.39189859 |
88 | MELK | 0.39009065 |
89 | IRAK2 | 0.38685954 |
90 | MAP3K7 | 0.37324159 |
91 | MAP2K6 | 0.35879752 |
92 | PDGFRB | 0.35829391 |
93 | ARAF | 0.35519638 |
94 | NUAK1 | 0.35079587 |
95 | INSR | 0.33315160 |
96 | PRKCH | 0.33260121 |
97 | RPS6KA1 | 0.33102251 |
98 | ERN1 | 0.31743296 |
99 | CAMKK2 | 0.27614793 |
100 | STK24 | 0.27229776 |
101 | RPS6KC1 | 0.26195908 |
102 | RPS6KL1 | 0.26195908 |
103 | FYN | 0.24774224 |
104 | TTN | 0.23809584 |
105 | RET | 0.23599486 |
106 | MARK2 | 0.22868893 |
107 | GSK3A | 0.22318361 |
108 | PDPK1 | 0.21568998 |
109 | MAP3K1 | 0.21474616 |
110 | SGK1 | 0.21244783 |
111 | MAP3K3 | 0.21056401 |
112 | PDK1 | 0.20698967 |
113 | PBK | 0.20561620 |
114 | CAMKK1 | 0.20549344 |
115 | IGF1R | 0.20471942 |
116 | MAP3K5 | 0.20380159 |
117 | TESK2 | 0.20024040 |
118 | NME2 | 0.19512006 |
119 | SIK1 | 0.19149178 |
120 | MAPK3 | 0.19120381 |
121 | PASK | 0.18398059 |
122 | RAF1 | 0.17479814 |
123 | CDK4 | 0.17218019 |
124 | BRD4 | 0.14964620 |
125 | TRPM7 | 0.13405993 |
126 | CDK9 | 0.13260259 |
127 | TGFBR1 | 0.13059556 |
128 | MAP3K8 | 0.13052145 |
129 | CDK6 | 0.12975354 |
130 | STK11 | 0.12965094 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Allograft rejection_Homo sapiens_hsa05330 | 3.44675845 |
2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.39861759 |
3 | * NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 3.22394705 |
4 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.02118942 |
5 | Leishmaniasis_Homo sapiens_hsa05140 | 2.86304724 |
6 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.80694414 |
7 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.71772387 |
8 | Measles_Homo sapiens_hsa05162 | 2.70531162 |
9 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.45658531 |
10 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.44241966 |
11 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.28371210 |
12 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.23036289 |
13 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.23009758 |
14 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.13250074 |
15 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.11375175 |
16 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.05457152 |
17 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.02929648 |
18 | * TNF signaling pathway_Homo sapiens_hsa04668 | 2.00797290 |
19 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.97844552 |
20 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.90959630 |
21 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.86051165 |
22 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.84379105 |
23 | Influenza A_Homo sapiens_hsa05164 | 1.75425714 |
24 | Other glycan degradation_Homo sapiens_hsa00511 | 1.74638194 |
25 | Legionellosis_Homo sapiens_hsa05134 | 1.73743323 |
26 | * Herpes simplex infection_Homo sapiens_hsa05168 | 1.64174538 |
27 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.60754545 |
28 | Asthma_Homo sapiens_hsa05310 | 1.58413589 |
29 | Malaria_Homo sapiens_hsa05144 | 1.57387691 |
30 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.54615109 |
31 | Viral myocarditis_Homo sapiens_hsa05416 | 1.49292818 |
32 | Tuberculosis_Homo sapiens_hsa05152 | 1.49292338 |
33 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.45851760 |
34 | Pertussis_Homo sapiens_hsa05133 | 1.40951361 |
35 | * Apoptosis_Homo sapiens_hsa04210 | 1.39817644 |
36 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.34590846 |
37 | Shigellosis_Homo sapiens_hsa05131 | 1.31551020 |
38 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.31380475 |
39 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.26171125 |
40 | Hepatitis B_Homo sapiens_hsa05161 | 1.25008480 |
41 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.23865299 |
42 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.22095748 |
43 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.21950346 |
44 | Hepatitis C_Homo sapiens_hsa05160 | 1.15028878 |
45 | Salmonella infection_Homo sapiens_hsa05132 | 1.12034126 |
46 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.11703112 |
47 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.03488998 |
48 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.00903937 |
49 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.96023794 |
50 | Prion diseases_Homo sapiens_hsa05020 | 0.95797292 |
51 | * Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.95721600 |
52 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.92283371 |
53 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.89418050 |
54 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.83163614 |
55 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.77135379 |
56 | HTLV-I infection_Homo sapiens_hsa05166 | 0.75780513 |
57 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.75570685 |
58 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.75191184 |
59 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.72741371 |
60 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.71349992 |
61 | * Small cell lung cancer_Homo sapiens_hsa05222 | 0.69034988 |
62 | * Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.68076858 |
63 | Bladder cancer_Homo sapiens_hsa05219 | 0.66390932 |
64 | * Viral carcinogenesis_Homo sapiens_hsa05203 | 0.63159055 |
65 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.60181497 |
66 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.60113618 |
67 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.57973278 |
68 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.57581380 |
69 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.57224385 |
70 | Platelet activation_Homo sapiens_hsa04611 | 0.55928429 |
71 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.55027660 |
72 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.51914012 |
73 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.49871353 |
74 | Amoebiasis_Homo sapiens_hsa05146 | 0.49654814 |
75 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.48849982 |
76 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.45064543 |
77 | Insulin resistance_Homo sapiens_hsa04931 | 0.44048993 |
78 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.41142198 |
79 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.41124592 |
80 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.40263593 |
81 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.39095933 |
82 | Phagosome_Homo sapiens_hsa04145 | 0.38517900 |
83 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.38260030 |
84 | Lysosome_Homo sapiens_hsa04142 | 0.37442296 |
85 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.35871374 |
86 | Endocytosis_Homo sapiens_hsa04144 | 0.33119068 |
87 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.30984449 |
88 | Colorectal cancer_Homo sapiens_hsa05210 | 0.30290896 |
89 | Prostate cancer_Homo sapiens_hsa05215 | 0.30183538 |
90 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.28970793 |
91 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.28600735 |
92 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.28427876 |
93 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.26112259 |
94 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.24256917 |
95 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.23400790 |
96 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.22231552 |
97 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.21467732 |
98 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.19305655 |
99 | * Pathways in cancer_Homo sapiens_hsa05200 | 0.19266499 |
100 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.19167223 |
101 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.19081143 |
102 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.17773921 |
103 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.15466228 |
104 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.13514876 |
105 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.13406248 |
106 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.12972438 |
107 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.12360732 |
108 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.10747498 |
109 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.10639105 |
110 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.09282901 |
111 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.07935664 |
112 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.05226929 |
113 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.04876158 |